AMRN : Analysis & Opinions

  1. AstraZeneca Looks To Fish Oil To Round Out Its Cardio Portfolio

    May 28, 2013
    AstraZeneca validates the purified fish oil concept, but not at an especially high price.
  2. Another Negative Fish Oil Study Adds To Amarin's Marketing Challenges

    May 9, 2013
    More questions about the real efficacy of fish oil is bad news for Amarin.
  3. Alexion Pharmaceuticals and More Big Movers in Healthcare on ...

    December 7, 2012
    So far today, the Nasdaq is down 0.7%, the S&P 500 is unchanged and the Dow is trading up 0.3%. The healthcare sector ...
  4. BASF's Deal For Pronova Shows The Importance Of Good Nutrition

    November 23, 2012
    BASF ties up another high-grade fish oil company in Pronovna, adding to the recent rise in popularity for the fish oil space.
  5. Healthcare Sector's Biggest Movers: HCA Holdings and More

    August 6, 2012
    The market is currently up, with the Nasdaq climbing 1%, the S&P 500 rising 0.5% and the Dow up 0.6%. The healthcare ...
  6. Biggest Healthcare Sector Movers, Including SHPG

    July 31, 2012
    After the morning's trading, the Nasdaq is trading up 0.4%, the S&P 500 remains relatively unchanged and the Dow is unchanged. ...
Trading Center